Viewing Study NCT02059759


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-02-20 @ 6:46 PM
Study NCT ID: NCT02059759
Status: COMPLETED
Last Update Posted: 2025-11-17
First Post: 2014-02-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2
Sponsor: Centre Hospitalier Universitaire de Nīmes
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: LOCAL/2014/WC-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators